Media & Feeds for CHO cell line
Product Description
UGA Biopharma GmbH
-
DE -
2023On CPHI since
-
1Certificates
-
25 - 49Employees
Company types
Primary activities
Categories
Specifications
UGA Biopharma GmbH
-
DE
-
2023On CPHI since
-
1Certificates
-
25 - 49Employees
Company types
Primary activities
More Products from UGA Biopharma GmbH (3)
-
Product Cell line development services
Cell line development services, including molecular cloning, CHO cell line development and lead clone selection, bioprocess optimization, DSP and analytical characterization of the target molecule.
-
Product Ready to use cell lines
Ready to use cell lines -
Product Ready-to Use CHO cell lines
UGA Biopharma GmbH offers to their clients so called Ready-to-use Biosimilar Cell Lines. This are in-house developed CHO cell lines stably expressing different biosimilar molecules, that are instantly available for in-licensing. The client profits, because the cell lines are directly available, and develop...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance